Author

György Lázár 1

1 University of Szeged,Szeged,Hungary;;

CHARACTERIZATION OF HCO3 SECRETION IN HUMAN PANCREATIC DUCTAL ORGANOID CULTURES

Arpad Varga, Tamara Madacsy, Aletta Kiss, Viktória Szabó, Margit Németh, Tamás Takács, Gyula Farkas Jr., Edit Szederkenyi, György Lázár, Peter Hegyi, József Maléth, Petra Pallagi

INTERPLAY OF ORAI1 CA2+ CHANNEL AND CYSTIC FIBROSIS TRANSMEMBRANE CONDUCTANCE REGULATOR (CFTR) IN EPITHELIAL PHYSIOLOGY

Arpad Varga, Marietta Görög, Boldizsár Jójárt, Viktória Szabó, Aletta Kata Kiss, Anita Balazs, Bálint Tél, Tamara Madacsy, Petra Pallagi, Gyula Farkas, Edit Szederkenyi, József Maléth, György Lázár

LONG-TERM OUTCOME OF PERIANAL AND ENTEROCUTANEUS FISTULIZING CROHN’S DISEASE TREATED WITH TUMOR NECROSIS FACTOR ALPHA (TNF-Α) ANTAGONISTS

Renáta Bor, Klaudia Farkas, Zoltan Gabor Szepes, Anita Balint, Ferenc Nagy, Szabolcs Ábrahám, Gellért Baradnay, György Lázár, Tibor Wittmann, Tamás Molnár

POSTOPERATIVE RECURRENCE OF CROHN?S DISEASE AND ITS ASSOCIATION WITH PLEXITIS

Ágnes Milassin, Anita Sejben, László Tiszlavicz, György Lázár, Renáta Bor, Anita Balint, Mariann Rutka, Zoltan Gabor Szepes, Klaudia Farkas, Tamás Molnár

THE DIAGNOSTIC ACCURACY OF FECAL CALPROTECTIN IN POUCHITIS

Anita Balint, Klaudia Farkas, György Lázár, Ferenc Nagy, Zoltan Gabor Szepes, Renáta Bor, Tibor Wittmann, Tamás Molnár

THE NEW FECAL MARKER MATRIX METALLOPROTEASE-9 IS MORE SENSITIVE FOR DIAGNOSING ULCERATIVE COLITIS AND POUCHITIS AND FOR DIFFERENTIATING THEM FROM CROHN’S DISEASE THAN FECAL CALPROTECTIN

Klaudia Farkas, Zoltán Sarodi, Anita Balint, György Lázár, Zsolt Simonka, Ferenc Nagy, Zoltan Gabor Szepes, Renáta Bor, Anita Annaházi, Richard Roka, Tibor Wittmann, Tamás Molnár

Item 1 - 6 / 9
1